Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By DataHorizzon Research
02 févr. 2024 06h40 HE
|
DataHorizzon Research
Fort Collins, Colorado, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The Hepatitis C Drug Market was valued at USD 20.8 Billion in 2022 and is anticipated to reach USD 26.9 Billion by 2032 at a CAGR of 2.7%. ...
Hepatitis C Drug Market Size & Share to Surpass $56.5 Billion by 2030 | Vantage Market Research
17 août 2023 05h30 HE
|
Vantage Market Research
WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to...
Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States
20 juil. 2023 12h00 HE
|
CDA Foundation
LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq:...
HepVu and NASTAD Release Inaugural Viral Hepatitis Surveillance Status Report
25 oct. 2022 10h32 HE
|
HepVu
ATLANTA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Today, HepVu and NASTAD released the first-ever assessment of viral hepatitis surveillance practices across U.S. jurisdictions, showing that while public...
Global Liver Fibrosis Treatment Market to Surpass US$ 33.4 Billion by 2030, Says Coherent Market Insights (CMI)
08 août 2022 09h10 HE
|
CMI
Seattle, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global liver fibrosis treatment market is estimated to be valued at US$ 14.7 billion in 2022 and is expected to...
HepVu Launches County-Level Hepatitis C-Related Mortality Data and Maps Visualizing Hepatitis C’s Impact on Americans at the Local-Level
03 mars 2021 12h44 HE
|
HepVu
ATLANTA, March 03, 2021 (GLOBE NEWSWIRE) -- Today, HepVu released new interactive maps visualizing U.S. county-level Hepatitis C-related mortality, illustrating how factors such as age and...
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
02 mars 2021 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Cocrystal Pharma Inc.’s Structure-Based Technology has Demonstrated Broad Utility in Development of Antivirals
13 févr. 2020 08h30 HE
|
Cocrystal Pharma, Inc.
– Positive preclinical and clinical data obtained to date in hepatitis C, influenza and norovirus programs bolster confidence in potential of our platform to address additional viral diseases,...
Actor Ernie Hudson to serve as national spokesperson for Think About the Link
16 déc. 2019 12h48 HE
|
Prevent Cancer Foundation
Alexandria, Va., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Ernie Hudson is best known for his role in the 1984 cult classic, Ghostbusters; however few fans know him as two-time cancer survivor. Hudson was...
Hearts from Hepatitis C patients are safe to transplant, research shows
04 avr. 2019 10h30 HE
|
International Society for Heart & Lung Transplantation
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- A growing body of research suggests that heart transplantation from donors with active Hepatitis C (HCV) is safe – and that the virus successfully...